Calibration and Evaluation of an Audio Pulse Oximeter Sensor (AudioOx) at Ascent and Descent From Simulated Altitude

June 22, 2017 updated by: Mark Ansermino, University of British Columbia
Pulse oximetry is a standard non-invasive method of measuring blood oxygen saturation (SpO2). In developing countries, pulse oximeters are rare because of expense and electricity requirements. Our ECEM group has developed the Phone Oximeter, which uses a cell phone (which are widely available in developing countries) to compute and analyze information from a pulse oximeter sensor. To further reduce costs, we have developed an oximeter sensor (AudioOx) that plugs into the audio jack of a standard cell phone. This study aims to calibrate the AudioOx by exposing 30 healthy adult volunteers to various altitudes in UBC's hypoxia chamber.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Purpose:

We at the Electrical and Computer Engineering in Medicine Group (ECEM) at the University of British Columbia, Vancouver, Canada, plan to make pulse oximetry available to resource poor countries by designing a low-cost, battery-powered pulse oximeter device consisting of a low-cost pulse oximeter sensor connected to a cell phone. The use of cell phones as patient monitors is appealing as they are widely available in many developing countries. Utilizing battery power, cell phones do not rely on a continuous source of electricity. This is essential, as most low-resource settings lack adequate infrastructure and thus cannot provide the uninterrupted power supply required for conventional patient monitoring. Furthermore, a cell phone has the efficiency, integrated display, and processing power required to analyze and store the raw data derived from the pulse oximeter sensors. Data from the pulse oximeter can be transmitted to referral centers for diagnostic and advisory purposes where cellular and networking services permit.

Proprietary oximeter sensors and modules are expensive. To reduce cost, we are proposing to develop a simple audio pulse oximeter sensor (AudioOx) that that does not require a sensor module and interfaces via the audio jack of any standard cell phone. By utilizing the audio jack for transmission of data from the sensor to phone, we can ensure that cell phone types most common in various areas of the world are universally supported. Preliminary laboratory tests showed that oximetry data from the AudioOx has sufficient signal strength and resolution for extraction of heart rate and SpO2.

Hypothesis:

We hypothesize that this study will allow us to successfully calibrate the AudioOx.

Justification:

Development of pulse oximeters requires calibration and evaluation for accuracy. There is no acceptable surrogate calibration tool for pulse oximeters. To quote the current International Organization for Standardization (ISO) Pulse Oximetry standard document: "There is today no accepted method of verifying the correct calibration of a pulse oximeter probe/pulse oximeter monitor combination other than testing on human beings. This is due to the complexity of the optical intricacies of the interaction of light and human tissue upon which pulse oximetry depends".

A previous calibration study was performed on volunteers during a concurrent study in the UBC hypoxia chamber. The results demonstrated that the AudioOx can be calibrated to within the 4% accuracy required by ISO. The study setup, however, was suboptimal as the measured SpO2 data was predominantly hypoxic. Motion artifacts were also abundant, as the subjects had unrestricted movement.

Objectives:

Our main objective is to improve the calibration of the AudioOx by:

  • Asking subjects to remain relatively immobile during data measurement.
  • Exposing subjects to a very gradual change in oxygen concentration so that measurements are distributed over the entire clinical range of SpO2 (70% to 100%).
  • Using two (instead of one) clinically-approved pulse oximeters from different manufacturers as secondary reference standards.

Our secondary objective is to evaluate and compare the performance of the AudioOx during motion, low perfusion, and rapidly changing SpO2 by:

  • Asking the subjects to perform standardized hand and finger motions during data measurement.
  • Simulating low perfusion via two methods: by partially occluding the brachial artery using a blood pressure cuff and by having the patient raise their arm for two minutes and using light filters to reduce the red and infra-red signals detected by the pulse oximeter sensors.
  • Measuring SpO2 as the subject enters and exits the hypoxia chamber.

Research Method:

This will be a non-invasive concurrent observational study of healthy voluntary adult subjects in a normobaric (sea-level atmospheric pressure) hypoxia (low oxygen) chamber.

Study subjects will be put into a hypoxic state by exposing them to normobaric hypoxia by administrating an air mix containing a reduced O2 concentration. This is achieved in a hypoxia chamber where O2 concentration is gradually reduced to simulate high altitude (about 4500 m).

The goals of the current study are very similar to another study conducted in the hypoxia chamber (REB ID#H12-02362, The Camera Oximeter), the same methodology is applied. This will allow recruiting subjects for both studies and will reduce the total number of subjects necessary for achieving our goal.

Statistical Analysis:

Calibration of SpO2 Data from the initial set of subjects (at least 10) in the study will be used to calibrate the AudioOx oximetry data. Firstly, ratio R is calculated from the red and infra-red (IR) photo-absorbance signals, where

R = ( ACRED / DCRED ) / ( ACIR / DCIR )

ACRED and ACIR are pulsatile components of the red and infra-red light detected by the oximeter photosensor. DCRED and DCIR are constant components of the red and infra-red light detected by the oximeter photosensor.

R values are paired to the reference SpO2 values (average of the two readings from the two reference pulse oximeters) and plotted on a scatter plot. Depending on the shape of the plot, the R values are translated to SpO2 values using a linear equation, multiple linear equations, or polynomial equations.

Evaluation of Accuracy

Readings from the oximeter sensors are grouped into six ranges (70-75%, 76-80%, 81-85%, 86-90%, 91-95% and 96-100%). For each range of SpO2 and the overall range (70-100%) accuracy will be calculated as per ISO definitions:

Accuracy of the pulse oximeter shall be stated in terms of the root-mean-square (rms) difference between AudioOx values (SpO2i) and reference values (SRi), as given by:

Arms = √((∑i=1 to n(SpO2i- SRi)^2 )/n)

To express Accuracy relative to the "gold-standard" blood gas analysis, the error of the secondary standard pulse oximeter (errorref) will be included:

Accuracy = √(Arms^2 + error(ref)^2)

Motion & low perfusion will be quantified by the proportion of time that the test measurements either gave no readings or were more than 4% different from the corresponding control measurements.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6H 3V4
        • BC Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Non-smokers
  • UBC students age 18 and older or non-university students age 19 and older
  • No medical history of respiratory, cardiovascular and neurological problems (capable of undergoing controlled hypoxemia down to SpO2 of 70%).

Exclusion Criteria:

  • Medical history including respiratory, cardiovascular and neurological problems
  • Smokers or individuals exposed to high levels of carbon monoxide that result in elevated carboxyhemoglobin levels (interferes with oximetry readings)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Normobaric hypoxia chamber
Study subjects will be put into a hypoxic state by exposing them to normobaric hypoxia by administrating an air mix containing a reduced O2 concentration. This is achieved in a hypoxia chamber where O2 concentration is gradually reduced to simulate high altitude (about 4500 m).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen saturation
Time Frame: Across 3 hours
Accurately calibrated AudioOx for measuring oxygen saturation
Across 3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: Across 3 hours
Accurately calibrated AudioOx for measuring heart rate
Across 3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (ACTUAL)

August 1, 2013

Study Completion (ACTUAL)

August 1, 2013

Study Registration Dates

First Submitted

November 16, 2012

First Submitted That Met QC Criteria

November 16, 2012

First Posted (ESTIMATE)

November 22, 2012

Study Record Updates

Last Update Posted (ACTUAL)

June 26, 2017

Last Update Submitted That Met QC Criteria

June 22, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • H12-02365

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Rate

Clinical Trials on Normobaric hypoxia chamber

3
Subscribe